FOI release

VMD FOI/EIR Requests May 2026

Freedom of Information/Environmental Information Regulation requests for May 2026.

• From: Veterinary Medicines Directorate
• Published: 12 August 2026

Documents

FOI2026/00812 - Librela adverse effects

HTML

Attachment for FOI2026/00812.

PDF, 89.4 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

FOI2026/00818 - Assessment/approval/and/or post-authorisation monitoring of Librela and Solensia

HTML

Attachment 1 for FOI2026/00818

PDF, 66.5 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Attachment 2 for FOI2026/00818

PDF, 415 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

FOI2026/00821 - Adverse event reporting line in operation

HTML

FOI2026/00822 - Usage of non-disclosure agreements

HTML

FOI2026/00904 - Private healthcare cover

HTML

FOI2026/00905 - Adverse event report line

HTML

FOI2026/00921 - Secondments, Consultancy and Post-Employment Movement of VMD staff

HTML

FOI2026/00929 – Neonicotinoids sales

HTML

FOI2026/00964 - Librela adverse event reports

HTML

Attachment for FOI2026/00964

PDF, 89.4 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

FOI2026/00967 – Information on Leptospirosis

HTML

FOI2026/00980 - Use of spotinor in lactating mares and foals.

HTML

FOI2026/00987 - SIC's for Bronopol (active ingredient) 2025-2026

HTML

FOI2026/00993 – Information on a specific adverse event report

HTML

FOI2026/00995 - Librela and Solensia Specific Fees and Estimated Animals Treated

HTML

FOI2026/01029 – Veterinary Safety Communication

HTML

Image for FOI2026/01029

PNG, 47.3 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email postmaster@vmd.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The responses to FOI/EIR requests received in May 2026 are published here.

Published 12 August 2026